Replies to post #906 on Synaptogenix Inc (SNPX)

[SF Wolf]

Hanuman, Bigger Capital is an investment fund. As of November 2016 they claimed to own 1.5 million shares of NTRP.

This is a very interesting read:

One quote: "The FDA is DESPERATE to shuttle through any therapeutic that is showing disease modifying activity in AD.  If Anavex (AVXL) can have multi-hundred million mkt cap so can NTRP. NTRP has the ear and eyes of the FDA, and back by reputable science and scientist."

http://biggercapital.squarespace.com/biggercapital-investment/2016/11/20/our-second-alzheimers-investment-neurotrope.html